Catecholaminergic Polymorphic Ventricular Tachycardia, also known as cpvt, is related to ventricular tachycardia, catecholaminergic polymorphic, 3 and ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy, and has symptoms including seizures and syncope. An important gene associated with Catecholaminergic Polymorphic Ventricular Tachycardia is CASQ2 (Calsequestrin 2), and among its related pathways/superpathways are Activation of cAMP-Dependent PKA and CREB Pathway. The drugs Calcium, Dietary and Calcium have been mentioned in the context of this disorder. Affiliated tissues include heart and cardiac myocytes, and related phenotypes are ventricular tachycardia and vertigo